American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

By D. Pfister, David H. Johnson, C. Azzoli, W. Sause, Thomas J. Smith, Sherman Baker, J. Olak, D. Stover, John R. Strawn, A. Turrisi and 1 more. Journal of Clinical Oncology, 2004

1,386 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/ac2a8b9ea1e5aa0d220ea5af90e6e02e284d8840

Citations in the corpus

• Angiogenesis in Cancer (2006, neutral): “…has curative potential, but the use of radiation and cytotoxic chemotherapy is a more appropriate route of treatment for surgically unresectable tumors (Kim et al 2002; Long 2003; Brenner et al 2004; Pfister et al 2004; Lin and Beerm 2004; Awada and de Castro 2005; Evans 2005; Goldberg 2005).”
• Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries (2017, neutral): “Other prognostic factors have been identified, such as performance status (13–15), weight loss (13, 14), presence of comorbidity (15), chemotherapy use in combination with RT (13, 16), radiation dose (13, 17), tumor size (12, 18–21), and image features, the so-called radiomics approach (22–26).”